LDC is the famous VC, which was founded in 1981. The fund was located in Europe if to be more exact in United Kingdom. The main department of described VC is located in the London.
Among the most popular portfolio startups of the fund, we may highlight CSR, Vista Retail Support, BioVex. The fund has exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 16-20 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Information Technology, Travel.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the LDC, startups are often financed by West Deutsche Landesbank Girozentrale, The North West Fund, Technomark Medical Ventures. The meaningful sponsors for the fund in investment in the same round are Scottish Equity Partners, West Deutsche Landesbank Girozentrale, Vendis Capital. In the next rounds fund is usually obtained by Scottish Equity Partners, Triathlon Medical Venture Partners, New Science Ventures.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 50 percentage points more often commits exit comparing to other organizations. When the investment is from LDC the average startup value is 50-100 millions dollars. The increased amount of exits for fund were in 2013. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. Opposing the other organizations, this LDC works on 17 percentage points more the average amount of lead investments.
The overall number of key employees were 59.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Atlantic Healthcare | $24M | 01 Nov 2016 | Uttlesford, England, United Kingdom | ||
OnApp | $20M | 16 Jan 2013 | United Kingdom, England | ||
Atlantic Healthcare | $23M | 01 Jan 2013 | Uttlesford, England, United Kingdom | ||
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Atlantic Healthcare | $24M | 01 Nov 2016 | Uttlesford, England, United Kingdom | ||
OnApp | $20M | 16 Jan 2013 | United Kingdom, England | ||
Atlantic Healthcare | $23M | 01 Jan 2013 | Uttlesford, England, United Kingdom | ||
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom |